论文部分内容阅读
本文观察腹蛇抗栓酶治疗肾病前后血粘度等指标变化。结果发现，观察组完全缓解率高于对照组，但无统计学意义，远期复发率明显低于对照组Ｐ＜０．０５，腹蛇抗栓治疗后血粘度下降，血小板聚集功能明显受到抑制Ｐ＜０．０５。结果表明，肾病患儿存在高粘、高凝状态，腹蛇抗栓酶具有治疗肾病高粘血症的作用。
In this paper, ventral constrictor antithrombin enzyme treatment of renal disease before and after changes in blood viscosity and other indicators. The results showed that the complete remission rate in the observation group was higher than that in the control group, but there was no statistical significance. The long-term recurrence rate was significantly lower than that in the control group (P <0.05). The blood viscosity decreased after the antithrombotic treatment and the platelet aggregation function was obviously inhibited P <0.05. The results show that there is a high viscosity, hypercoagulable state in children with nephrotic syndrome, abdominal snake antithrombotic enzyme has the role of treatment of hyperviscosity of kidney disease.